Yang Yu-Fan, Liu Lin-Lin, Huang Ming-Jie, Ma Zheng-Min, Huo Wen-Wen, Zhu Ya-Juan, Liu Hong, Peng Ke, Ji Fu-Hai
Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
Institute of Anesthesiology, Soochow University, Suzhou, Jiangsu, People's Republic of China.
Int J Gen Med. 2023 Aug 25;16:3789-3796. doi: 10.2147/IJGM.S426245. eCollection 2023.
Postoperative complications are common after major surgical procedures, leading to increased morbidity and mortality. Regional cerebral oxygen saturation (rScO) reflects cerebral and global perfusion, and thus it can be used to guide hemodynamic management. We aim to explore the effect of rScO-guided blood pressure management strategy on postoperative major complications in older adults who undergo major noncardiac surgery.
This randomized controlled clinical trial includes a total of 400 elderly patients receiving major noncardiac surgery and general anesthesia. Patients will be randomized (1:1) to one of two blood pressure management groups: a standard care group (targeting mean arterial pressure >65 mmHg or within 20% of baseline value), and a rScO-guided group (absolute value of rScO >60% or decrease in rScO <10% of baseline). The primary outcome is the composite outcome of major complications (including infectious, respiratory, neurologic, cardiovascular, renal, thromboembolic gastrointestinal, and surgical complications) and deaths within the first 7 days after surgery. Secondary outcomes include the individual components of the primary outcome by day 7 after surgery and 30-day mortality. Data will be analyzed in the modified intention-to-treat population.
This study will provide evidence for improving postoperative outcomes using the rScO-guided blood pressure management among older adults who undergo major noncardiac surgery.
Chinese Clinical Trial Registry (Identifier: ChiCTR2200060816).
大手术术后并发症很常见,会导致发病率和死亡率上升。局部脑氧饱和度(rScO)反映脑灌注和整体灌注,因此可用于指导血流动力学管理。我们旨在探讨rScO指导的血压管理策略对接受非心脏大手术的老年人术后主要并发症的影响。
这项随机对照临床试验共纳入400例接受非心脏大手术并接受全身麻醉的老年患者。患者将被随机(1:1)分为两个血压管理组之一:标准治疗组(目标平均动脉压>65 mmHg或在基线值的20%以内)和rScO指导组(rScO绝对值>60%或rScO较基线值下降<10%)。主要结局是术后第1个7天内主要并发症(包括感染、呼吸、神经、心血管、肾脏、血栓栓塞性胃肠道和手术并发症)和死亡的复合结局。次要结局包括术后第7天主要结局的各个组成部分和30天死亡率。将在改良意向性治疗人群中分析数据。
本研究将为在接受非心脏大手术的老年人中使用rScO指导的血压管理改善术后结局提供证据。
中国临床试验注册中心(标识符:ChiCTR2200060816)。